Alfred Health
Prostate, melanoma and rare cancer clinical trials will soon be available for patients in Gippsland thanks to a new partnership between Alfred Health and Latrobe Regional Hospital.
Alfred Health researchers will play a major role in developing a global Fungal Pathogen Priority List (PPL) which will shed light on an often-overlooked group of infections.
A new device that targets hard-to-kill tumours is the focus of a research trial led by The Alfred's interventional radiology team.
With the new model of a Vagal Nerve Stimulator (VNS), our neurology team can pre-program our epilepsy patients treatment months in advance - meaning they can visit the hospital less often.
A dramatic rise in road trauma admissions has Alfred Health specialists urging motorists to stay safe to prevent further trauma this Easter long weekend.
Researchers at Melbourne Sexual Health Centre (MSHC) have been granted more than $1.25 million by the National Health and Medical Research Council (NHMRC) to develop new strategies for detecting and controlling syphilis.
Alex has suffered from epilepsy since he was 16 years old, he has up to three seizures a week, usually while he’s sleeping. Alex spent last week in our neurology clinical trials ward, the only one of its kind in Australia – to try get to the bottom of his seizures.
A study conducted at The Alfred has proved what researchers had already predicted – that the neurological effects of COVID-19 could remain present months after the virus has been shed.
Earlier today, Victorian Premier Daniel Andrews was discharged from hospital to start a significant period of rehabilitation through our Better@Home service.
Today, the Victorian Premier will move from the intensive care unit, into a ward at The Alfred